Yuan F, Fu X, Shi H, Chen G, Dong P, Zhang W
The challenge for the next few years is making sure patients are able to access them. In their latest analysis, Tsai and his colleagues found that among the commercially insured, less than 1% of people with obesity were being treated with either surgery or GLP-1 drugs, underscoring that despite the shifts underway, obesity remains a profoundly underaddressed public health issue
Vic gim sn xut melanin gip lm sng da, gim thm nm, tn nhang v cc vn v sc t da
Additionally, deficiencies in insulin availability are known to contribute to neurodegenerative conditions, but GLP-1s amplify insulin signaling in brain cells, increasing insulin sensitivity in the neurons
Aug 30 2010;6(4):513-518